These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs]. Xue J; Jiang B; Liu CS; Sun J; Xiao SH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850 [TBL] [Abstract][Full Text] [Related]
3. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials. Tripathi AK; Gupta A; Garg SK; Tekwani BL Life Sci; 2001 Oct; 69(23):2725-33. PubMed ID: 11720077 [TBL] [Abstract][Full Text] [Related]
4. In vitro antimalarial activity of ICL670: a further proof of the correlation between inhibition of β-hematin formation and of peroxidative degradation of hemin. Sonnet P; Mullié C Exp Parasitol; 2011 May; 128(1):26-31. PubMed ID: 21295029 [TBL] [Abstract][Full Text] [Related]
5. A novel endogenous antimalarial: Fe(II)-protoporphyrin IX alpha (heme) inhibits hematin polymerization to beta-hematin (malaria pigment) and kills malaria parasites. Monti D; Vodopivec B; Basilico N; Olliaro P; Taramelli D Biochemistry; 1999 Jul; 38(28):8858-63. PubMed ID: 10413458 [TBL] [Abstract][Full Text] [Related]
6. The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs. Zhang J; Krugliak M; Ginsburg H Mol Biochem Parasitol; 1999 Mar; 99(1):129-41. PubMed ID: 10215030 [TBL] [Abstract][Full Text] [Related]
7. Haematin (haem) polymerization and its inhibition by quinoline antimalarials. Ridley RG; Dorn A; Vippagunta SR; Vennerstrom JL Ann Trop Med Parasitol; 1997 Jul; 91(5):559-66. PubMed ID: 9329993 [TBL] [Abstract][Full Text] [Related]
8. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Fitch CD Life Sci; 2004 Mar; 74(16):1957-72. PubMed ID: 14967191 [TBL] [Abstract][Full Text] [Related]
10. Targeting of hematin by the antimalarial pyronaridine. Auparakkitanon S; Chapoomram S; Kuaha K; Chirachariyavej T; Wilairat P Antimicrob Agents Chemother; 2006 Jun; 50(6):2197-200. PubMed ID: 16723583 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait. Martiney JA; Cerami A; Slater AF Mol Med; 1996 Mar; 2(2):236-46. PubMed ID: 8726466 [TBL] [Abstract][Full Text] [Related]
12. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328 [TBL] [Abstract][Full Text] [Related]
13. Quinoline antimalarials decrease the rate of beta-hematin formation. Egan TJ; Ncokazi KK J Inorg Biochem; 2005 Jul; 99(7):1532-9. PubMed ID: 15927260 [TBL] [Abstract][Full Text] [Related]
14. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization. Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844 [TBL] [Abstract][Full Text] [Related]
15. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Parapini S; Basilico N; Pasini E; Egan TJ; Olliaro P; Taramelli D; Monti D Exp Parasitol; 2000 Dec; 96(4):249-56. PubMed ID: 11162378 [TBL] [Abstract][Full Text] [Related]
16. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses. Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352 [TBL] [Abstract][Full Text] [Related]
17. Bis-alkylamine Indolo[3,2-b]quinolines as hemozoin ligands: implications for antimalarial cytostatic and cytocidal activities. Paulo A; Figueiras M; Machado M; Charneira C; Lavrado J; Santos SA; Lopes D; Gut J; Rosenthal PJ; Nogueira F; Moreira R J Med Chem; 2014 Apr; 57(8):3295-313. PubMed ID: 24673163 [TBL] [Abstract][Full Text] [Related]
18. Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay. Tekwani BL; Walker LA Comb Chem High Throughput Screen; 2005 Feb; 8(1):63-79. PubMed ID: 15720198 [TBL] [Abstract][Full Text] [Related]
19. A common mechanism for blockade of heme polymerization by antimalarial quinolines. Sullivan DJ; Matile H; Ridley RG; Goldberg DE J Biol Chem; 1998 Nov; 273(47):31103-7. PubMed ID: 9813011 [TBL] [Abstract][Full Text] [Related]
20. Crystal nucleation, growth, and morphology of the synthetic malaria pigment beta-hematin and the effect thereon by quinoline additives: the malaria pigment as a target of various antimalarial drugs. Solomonov I; Osipova M; Feldman Y; Baehtz C; Kjaer K; Robinson IK; Webster GT; McNaughton D; Wood BR; Weissbuch I; Leiserowitz L J Am Chem Soc; 2007 Mar; 129(9):2615-27. PubMed ID: 17290993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]